Pegferon 180 mcg/0 5 ml, Injektionslösung in Fertigspritzen
Country: Switzerland
Language: French
Source: Swissmedic (Swiss Agency for Therapeutic Products)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
peginterferonum alfa-2a
Available from:
Roche Pharma (Schweiz) AG
ATC code:
L03AB11
INN (International Name):
peginterferonum alfa-2a
Pharmaceutical form:
5 ml, Injektionslösung in Fertigspritzen
Composition:
peginterferonum alfa-2a 180 µg, natrii chloridum, natrii acetas trihydricus, acidum aceticum glaciale, polysorbatum 80, conserv.: alcohol benzylicus 5 mg, aqua ad iniectabilia q.s. ad solutionem pro 0.5 ml.
Therapeutic group:
Biotechnologika
Therapeutic area:
Chronische Hepatitis B; chronische Hepatitis C
Authorization date:
2013-04-11
